This study also reveals that SETDB1-mediated PLK3 K106/200 methylation not only serves as a key signal driving HIF1α stability and BCSC properties but also acts as a prognostic factor for metastatic breast cancer patients. Here, PLK3 is linked to breast carcinoma.